Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility.
D000328:Adult; D000568:Amenorrhea / Q000150:complications / Q000188:drug therapy*; D001966:Bromine / Q000494:pharmacology / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000494:pharmacology / Q000627:therapeutic use*; D004967:Estrogens / Q000652:urine; D005260:Female; D005298:Fertility / Q000187:drug effects*; D006062:Gonadotropins / Q000652:urine; D006801:Humans; D007231:Infant, Newborn; D007775:Lactation Disorders / Q000150:complications / Q000188:drug therapy*; D008599:Menstruation Disturbances / Q000188:drug therapy; D010060:Ovulation / Q000187:drug effects*; D010907:Pituitary Hormones / Q000502:physiology; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000502:physiology; D013577:Syndrome
D004876:Ergot Alkaloids; D004967:Estrogens; D006062:Gonadotropins; D010907:Pituitary Hormones; D002996:Clomiphene; D004295:Dihydroxyphenylalanine; D011388:Prolactin; D011276:Pregnanediol; D001966:Bromine